Clinical Trials Browser

OTHER × Prostatic Neoplasms × HuMax-IL8 × Clear all

NCT03689699 2025-04-29

Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8)

Phase 1/2 Active not recruiting

59 enrolled 9 charts

Prostatic Neoplasms